cjc-1295 dac ipamorelin + CJC-1295 No DAC + Ipamorelin

Mechanism of Action: Receptor Binding:Ipamorelin's non-proteinogenic residues (particularly the bulky D-2-naphthylalanine) fit precisely into the hydrophobic binding pocket of GHS-R1a, creating a high-affinity, selective interaction

This hormonal selectivity makes it the GHRP with the most favorable tolerability profile

The preventive nature of Sermorelin therapy may also contribute to long-term healthcare cost savings by supporting optimal health and potentially reducing the risk of age-related health conditions that require expensive medical interventions

Practice stress reduction techniques

Within the first 20-day cycle: energy levels, reduced fatigue, improved endurance, and faster recovery from exertion are typically the first effects patients notice